PsychRights^®
                   Law Project for
              Psychiatric Rights

Allostatic Load:
How Psychoactive Drugs Stress the Mind & Body
Presentation and References
from Grace E. Jackson, M.D. Presentation
at 8th Annual ICSPP Conference
October 9, 2005, NYC

• Powerpoint Presentation (PDF -- 2.3 MB)

• Barondes, Samuel H.  Molecules and Mental Illness.  New York: Scientific American Library, 1999.

• Bonelli, Raphael M., Hofmann, Peter, Aschoff, Andreas, Niederwieser, Gerald, Heuberger, Clemens, Jirikowski, Gustaf, and Kapfhammer, Hans-Peter, “The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychotics.” International Clinical Psychopharmacology 20 (2005): 145-149.

• Guerrini, Renzo, Belmonte, Anna, Canapicchi, Raffaello, Casalini, Claudia, and Perucca, Emilio.  “Reversible Pseudoatrophy of the Brain and Mental Deterioration Associated with Valproate Treatment.”  Epilepsia 39 (1998): 27-32.

•  Heninger, G.R., Delgado, P.L., and Charney, D.S.  “The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in Humans.”  Pharmacopsychiatry 29 (1996): 2-11.

• Jackson, Grace E.  Rethinking Psychiatric Drugs: A Guide for Informed Consent.  Bloomington, IN: Author House, 2005.

• Jellinger, Kurt.  “Neuropathologic Findings after Neuroleptic Long -Term Therapy.” in Neurotoxicology.  Ed. L. Roizin, H. Shiraki, and N. Grcevic.  New York: Raven Press, 1977, pp. 25-42.

• Kalia, Madhu, O’Callaghan, James P., Miller, Diane B., and Kramer, Michael.  “Comparative study of fluoxetine, sibutramine, sertraline, and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.”  Brain Research 858 (2000): 92-105.

• Martin, Lee J., Al-Abdulla, Nael A., Brambrink, Ansgar M., Kirsch, Jeffrey R., Sieber, Frederick E., and Portera-Cailliau, Carlos.  “Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis.” Brain Research Bulletin 46 (1998): 281-309.

• McEwen, Bruce.  “Protective and Damaging Effects of Stress Mediators.”  NEJM 338             (1998): 171-179.

• Papazian, Oscar, Canizales, Elizabeth, Alfonso, Israel, Archila, Ricardo, Duchowny, Michael, and Aicardi, Jean.  “Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy.”  Annals of Neurology 38 (1995): 687-691.

• Ricaurte, George A., Mechan, Annis O., Yuan, Jie, Hatzidimitriou, George, Xie, Tao, Mayne, Andrew H., and McCann, Una D.  “Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates.”  Journal of Pharmacology and Experimental Therapeutics 315 (2005): 91-98.

•  Selye, Hans.  The Stress of Life.  Revised Ed.  New York: The McGraw-Hill Companies, Inc., 1984.

• Snell, Richard S.  Clinical Neuroanatomy for Medical Students.  Fourth Ed.  Philadelphia: Lippincott-Raven, 1997.

Last modified 10/23/2005